(Q36283838)

13 August 2017

1 reference

title

Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach (English)

1 reference

13 August 2017

C Ludlam

1

1 reference

13 August 2017

language of work or name

1 reference

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

11 Suppl 1

1 reference

13 August 2017

page(s)

7-10

1 reference

Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Cases of surgery in high-responder haemophilia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Elective orthopaedic surgery for inhibitor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

Recombinant activated factor VII for acute intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01152.X

10.1111/J.1365-2516.2005.01152.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference